Bortezomib and Low Dose Cytarabine in the Treatment of High-Risk Myelodysplastic Syndromes

The recruitment status of this study is unknown because the information has not been verified recently.

Verified December 2006 by Groupe Francophone des Myelodysplasies.
Recruitment status was Recruiting

Sponsor:

Information provided by:

Groupe Francophone des Myelodysplasies

ClinicalTrials.gov Identifier:

NCT00411905

First received: December 14, 2006

Last updated: March 9, 2007

Last verified: December 2006

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	June 2006
Estimated Primary Completion Date:	No date given